Stryker Corporation (NYSE:SYK) reported strong second-quarter 2026 operating results with consolidated net sales rising 9.4% to $6.6 billion, driven by organic growth across its MedSurg and Neurotechnology segments. The company highlighted a resilient recovery from a previously reported cyber incident, citing regained momentum in sales,...
Stryker Corp. (SYK) reported first-quarter earnings that exceeded Wall Street expectations, driven by strong revenue and profit performance. The Kalamazoo, Michigan-based medical device manufacturer posted a quarterly profit of $592 million, translating to $1.54 per share on the reported basis. On an adjusted basis, which...
MedSurg and Neurotechnology: $3.21 billion (ticker SYK) CEO Kevin Lobo confirmed that a significant cyberattack in mid-March 'meaningfully' impacted Stryker's first-quarter 2023 financial results, though the company maintained its full-year guidance for organic sales growth between 8% and 9.5% and adjusted earnings per share of...
Stryker Corporation reported strong second-quarter results with 9% organic sales growth and adjusted earnings per share of $3.69, representing a 17.9% year-over-year increase. The company achieved record installations for its Mako robotic system and saw high-single-digit growth in its MedSurg, Neurotechnology, and Orthopaedics segments as...
Fisher Asset Management LLC reduced its stake in Stryker Corporation (NYSE: SYK) by 5.8% during the fourth quarter, selling 192,839 shares and retaining a position valued at approximately $1.10 billion. This move coincides with Stryker's recent quarterly earnings miss, where the company reported EPS of...
Stryker Corporation (SYK) reported exceptional Q4 results with 11% organic sales growth, capping a year where revenues surpassed $25 billion for the first time. This marks the fourth consecutive year of double-digit expansion for the medical device giant. The company's standout performer was its Mako...
Stryker (NYSE: SYK) unveiled a suite of new orthopaedic innovations at the AAOS 2026 Annual Meeting in New Orleans, reinforcing its commitment to advancing care across multiple specialties. Key highlights include the commercial launch of Triathlon Gold, the first femoral component utilizing additive manufacturing and...
Stryker Corporation reported strong quarterly financial results, with adjusted earnings per share reaching $3.69, surpassing the consensus estimate of $3.49. Revenue for the quarter totaled $6.59 billion, slightly exceeding expectations and marking a 9.40% increase year-over-year. These figures indicate that the medical device maker is...
Stryker Corp. shares fell 21.6 percent to close at USD 274.19 on September 21, 2026, trading near its 52-week low of USD 267. The decline was primarily driven by TD Cowen downgrading its price target from USD 355 to USD 298 while maintaining a Hold...
Stryker Corp stock has stabilized near USD 280 on September 17, 2026, following a year-to-date decline of nearly 20 percent. The medical technology group is currently viewed as being in a transition phase by analysts at RBC Capital Markets, who cite a recent cyberattack and...
Stryker Corporation (SYK) shares experienced a sharp decline of 8.9% on Wednesday, trading at $276.16 and hitting a 52-week low of $275.10. This significant drop followed a downgrade by Wells Fargo, which slashed its price objective from $418 to $348 despite maintaining an Overweight rating....
Stryker Corporation (NYSE:SYK) saw insider Debra King sell 826 shares on August 18th at an average price of $336.30, reducing her position by 11.74% while retaining 6,210 shares valued at approximately $2.09 million. The transaction was disclosed to the SEC and occurred as the stock...
The article analyzes three major medical device companies—Intuitive Surgical (ISRG), Medtronic (MDT), and Stryker (SYK)—as key beneficiaries of the convergence between surgical robotics and artificial intelligence. It argues that these firms possess durable competitive moats through large installed bases of robotic systems that generate structured...
Andra AP fonden significantly increased its position in Stryker Corporation (NYSE:SYK) by 30.2% in the first quarter, purchasing an additional 15,095 shares to hold a total of 65,055 shares valued at $21.4 million. This move aligns with several other institutional investors who recently established new...
Bank of New York Mellon Corp reduced its stake in Stryker Corporation (NYSE:SYK) by 8.3% in the first quarter, selling 359,418 shares to hold a remaining position of 3,952,401 shares valued at approximately $1.3 billion. While BNY Mellon decreased its holding, several other institutional investors...
Stryker Corporation (SYK) is a global medical technology leader specializing in orthopedic implants, surgical equipment, and hospital infrastructure. Its diverse portfolio includes hip and knee replacement systems, trauma devices, spine products, endoscopic instruments, patient mobility solutions, and robotic-assisted surgery platforms like Mako. The company operates...
Stryker Corporation (SYK) is a global medical technology leader with a market cap of $118.4 billion, operating in Orthopaedics, MedSurg, and Neurotechnology. Despite facing an unexpected cyber disruption that impacted first-quarter results, the company maintains strong underlying demand, a robust capital order book, and significant...
Stryker has officially completed its acquisition of Amplitude Vascular Systems, a privately held medical technology firm based in Boston that specializes in treating severely calcified arterial disease. This deal marks a significant strategic milestone for Stryker as it seeks to expand its peripheral vascular portfolio...
Stryker, a major medical supply company based in Portage, Michigan, announced that its systems were disrupted by a cyberattack believed to have originated from Iran. The company stated that the incident is contained and does not believe ransomware or malware has entered their systems. Stryker...
Stryker (SYK) and ResMed are being compared as investment alternatives within the medical device sector, with Stryker positioned as a larger giant selling orthopedic products and capital equipment while ResMed focuses on sleep devices. The analysis highlights that while both companies have shared average sales...
